Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Langenbeck'S Archives of Surgery
|
January 15, 2013
Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone
Georgios Meimarakis, Martin Angele, Claudius Conrad, et al.
Endocrine-Related Cancer
|
January 5, 2019
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
Florian Bösch, Katharina Brüwer, Annelore Altendorf-Hofmann, et al.
Endocrine-Related Cancer
|
March 23, 2018
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
Elke Tatjana Aristizabal Prada, Vera Heinzle, Thomas Knösel, et al.
Journal of Cancer Research and Clinical Oncology
|
August 31, 2016
Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort
Ulrich Nitsche, Helmut Friess, Ayman Agha, et al.
Minerva Medica
|
September 12, 2017
Multidisciplinary treatment of colorectal liver metastases
Tobias S Schiergens, Jobst von Einem, Michael N Thomas, et al.
Stem Cells and Development
|
September 12, 2013
Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases
Yue Zhao, Qi Bao, Bettina Schwarz, et al.
International Journal of Cancer
|
February 26, 2019
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial
Jobst Christian von Einem, Christine Guenther, Hans-Dieter Volk, et al.
Oncotarget
|
November 9, 2017
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial
Jobst C von Einem, Sylvia Peter, Christine Günther, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2022
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
Sylvie Lorenzen, Michael Quante, Isabel Rauscher, et al.
JAMA Oncology
|
February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
Rolf D Issels, Lars H Lindner, Jaap Verweij, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Langenbeck'S Archives of Surgery
|
January 15, 2013
Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone
Georgios Meimarakis, Martin Angele, Claudius Conrad, et al.
Endocrine-Related Cancer
|
January 5, 2019
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
Florian Bösch, Katharina Brüwer, Annelore Altendorf-Hofmann, et al.
Endocrine-Related Cancer
|
March 23, 2018
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
Elke Tatjana Aristizabal Prada, Vera Heinzle, Thomas Knösel, et al.
Journal of Cancer Research and Clinical Oncology
|
August 31, 2016
Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort
Ulrich Nitsche, Helmut Friess, Ayman Agha, et al.
Minerva Medica
|
September 12, 2017
Multidisciplinary treatment of colorectal liver metastases
Tobias S Schiergens, Jobst von Einem, Michael N Thomas, et al.
Stem Cells and Development
|
September 12, 2013
Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases
Yue Zhao, Qi Bao, Bettina Schwarz, et al.
International Journal of Cancer
|
February 26, 2019
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial
Jobst Christian von Einem, Christine Guenther, Hans-Dieter Volk, et al.
Oncotarget
|
November 9, 2017
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial
Jobst C von Einem, Sylvia Peter, Christine Günther, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2022
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
Sylvie Lorenzen, Michael Quante, Isabel Rauscher, et al.
JAMA Oncology
|
February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
Rolf D Issels, Lars H Lindner, Jaap Verweij, et al.
Page
of 8